In the News
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes
An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
MKSAP Quiz: Recurrent symptomatic lower UTIs
A 32-year-old woman undergoes consultation for recurrent symptomatic lower urinary tract infections. They have increased in frequency over the past 3 years to a rate of about two times per year. What is the most appropriate management?
Illicitly manufactured fentanyls involved in increasing number of U.S. overdose deaths
From July 2019 to December 2020, sharp increases were seen in deaths involving illicitly manufactured fentanyls in midwestern (33.1%), southern (64.7%), and western (93.9%) jurisdictions, federal data indicate.
Annals of Internal Medicine: Clinical Cases now accepting submissions
ACP's newly launched journal, Annals of Internal Medicine: Clinical Cases, will consider original case report manuscripts and provide expert peer review, timely online publication, and immediate global open access.
ACP's 2021 end-of-year advocacy highlights: Advocating to support internists and their patients
From advancing the value of internal medicine and primary care to supporting internists' needs during the COVID-19 crisis, ACP has been actively working for members and patients.
Put words in our mouth
ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.